OBJECTIVE To identify and define clinically meaningful type 1 diabetes outcomes beyond
hemoglobin A1c (HbA1c) based upon a review of the evidence, consensus from clinical …

Hypoglycemia unawareness (HU) is defined at the onset of neuroglycopenia before the
appearance of autonomic warning symptoms. It is a major limitation to achieving tight …

JCM | Free Full-Text | Hypoglycemia in Patients with Diabetes and Renal Disease Next Article
in Journal Addisonian Crisis after Missed Diagnosis of Posttraumatic Hypopituitarism Next …

Hypoglycemia is a major problem associated with substantial morbidity and mortality in
patients with diabetes and is often a major barrier to achieving optimal glycemic control …

Type 1 diabetes is characterized by selective loss of beta cells and insulin secretion, which
significantly impact glucose homeostasis. However, this progressive disease is also …

Background: Across the world, the economic and health costs of diabetes are rising at an
alarming rate. Each year in the United States, billions of dollars are spent on T2 Diabetes …

Insulin with natural antioxidants is emerging as a combination treatment for diabetes mellitus
that attempts to exert effective glycemic control without adverse effects. The present study …

Hypoglycemia is uncommon in the general, nondiabetic population but occurs frequently in
persons with diabetes treated with insulin or insulin secretagogues. Thus, iatrogenic …

Neuronostatin (NST) is a recently described peptide that is produced from the somatostatin
preprohormone in pancreatic δ-cells. NST has been shown to increase glucagon secretion …

In health hypoglycaemia is rare and occurs only in circumstances like extreme sports.
Hypoglycaemia in type 1 Diabetes (T1D) and advanced type 2 Diabetes (T2D) are the result …